| 应用曲美他嗪对经皮冠状动脉介入治疗的影响 |
| |
| 引用本文： | 黄斌,秦龙飞,张丽娟,李新. 应用曲美他嗪对经皮冠状动脉介入治疗的影响[J]. 中国实用医药, 2007, 2(23): 12-13 |
| |
| 作者姓名： | 黄斌 秦龙飞 张丽娟 李新 |
| |
| 作者单位： | 450052,郑州,郑州大学第五附属医院介入科 |
| |
| 摘 要： | 目的探讨经皮冠状动脉介入治疗(Percutaneous coronary intervention,PCI)术前应用曲美他嗪对术中心肌缺血的影响。方法选择不稳定型心绞痛患者94例随机分为两组,常规治疗基础上,术前加服曲美他嗪行PCI术46例为实验组,48例行PCI术为对照组。观察两组患者术中ST段抬高或降低最大幅度,球囊扩张到ST段抬高或降低1mm的平均时间,发生心绞痛的例数及术后肌钙蛋白I的阳性率。结果PCI术中ST段抬高或降低最大幅度,球囊扩张到ST段抬高或降低1mm的平均时间,发生心绞痛的例数以及术后肌钙蛋白I阳性率两组比较差异均有统计学意义(P<0.05)。结论PCI术前应用曲美他嗪具有明确的抗心肌缺血和心肌保护作用。
|
| 关 键 词： | 曲美他嗪 经皮冠状动脉介入治疗 心肌缺血 |
Influence of applying trimetazidine before percutaneous coronary intervention |
| |
| HUANG Bin,QIN Long-fei,ZHANG Li-juan,et al.. Influence of applying trimetazidine before percutaneous coronary intervention[J]. China Practical Medical, 2007, 2(23): 12-13 |
| |
| Authors: | HUANG Bin QIN Long-fei ZHANG Li-juan et al. |
| |
| Affiliation: | HUANG Bin,QIN Long-fei,ZHANG Li-juan,et al.Department of Intervention,the Fifth Affiliated Hospital of Zhengzhou Medical University,Zhengzhou 450052,China |
| |
| Abstract: | Objective To study the influence of applying trimetazidine on myocardial ischemia before percutaneous coronary intervention(PCI).Methods 94 patients with unstable angia were randomly divided into the experiment group and the compare group.On the basis of routine treatment,46 patients of the experiment group were treated with trimetazidine before PCI,48 patients of the compare group were treated by PCI.The max range of ST decrease or increase,the average time of the balloon expanding to ST decrease or increase 1 mm,the number of angia taken place and the positive rate of cTnI after PCI were studied.Results There were significant differences(P<0.05)among the above indications in the two groups.Conclusion Applying trimetazidine before PCI shows significant benefits to against myocardial ischemia and myocardial protection. |
| |
| Keywords: | Trimetazidine Percutaneous coronary intervention Myocardial ischemia |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
